Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Costly Delays Threaten Japan’s Medical Hubs For Foreign Firms

This article was originally published in PharmAsia News

Executive Summary

The effort by Japan's government to attract foreign medical technology companies to a planned series of major hubs faces economic barriers. Many foreign companies are averse to making the investment to locate in the country because of Japan's high costs and its regulations. Massive development efforts already are underway on centers that would specialize in medical and biotechnology research and development, such as one in Kobe that has attracted the interest of 127 medical-related companies. The national government has offered support for such projects by designating cutting-edge medical industrial zones, but delays in other plans to make clinical trials easier to conduct have imposed costly delays on companies. (Click here for more - a subscription may be required



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts